File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Safe and effective use of digoxin in old age

TitleSafe and effective use of digoxin in old age
Authors
KeywordsAppropriate use
Digoxin
Efficacy
Therapeutic range
Toxicity
Issue Date2010
Citation
CME Journal Geriatric Medicine, 2010, v. 12, n. 2, p. 86-97 How to Cite?
AbstractDigoxin is a common cause of drug-related visits to emergency departments and of hospital admissions. This article promotes the safe prescribing of digoxin by reviewing appropriate indications for its use, manifestations of toxicity, appropriate dosing, therapeutic drug monitoring and clinical monitoring. The Digitalis Intervention Group trial and its post-hoc analyses have helped to redefine a lower and narrower therapeutic digoxin level of 0.6-1.2 nmol/L (0.5-0.9 ng/mL) in the treatment of heart failure. To ensure appropriate dosing clinicians must take into account inter-individual and intra-individual variability in pharmacokinetics and pharmacodyamics, which occur more commonly in older people. © 2010 Rila Publications Ltd.
Persistent Identifierhttp://hdl.handle.net/10722/250947
ISSN

 

DC FieldValueLanguage
dc.contributor.authorKong, T. K.-
dc.date.accessioned2018-02-01T01:54:09Z-
dc.date.available2018-02-01T01:54:09Z-
dc.date.issued2010-
dc.identifier.citationCME Journal Geriatric Medicine, 2010, v. 12, n. 2, p. 86-97-
dc.identifier.issn1475-1453-
dc.identifier.urihttp://hdl.handle.net/10722/250947-
dc.description.abstractDigoxin is a common cause of drug-related visits to emergency departments and of hospital admissions. This article promotes the safe prescribing of digoxin by reviewing appropriate indications for its use, manifestations of toxicity, appropriate dosing, therapeutic drug monitoring and clinical monitoring. The Digitalis Intervention Group trial and its post-hoc analyses have helped to redefine a lower and narrower therapeutic digoxin level of 0.6-1.2 nmol/L (0.5-0.9 ng/mL) in the treatment of heart failure. To ensure appropriate dosing clinicians must take into account inter-individual and intra-individual variability in pharmacokinetics and pharmacodyamics, which occur more commonly in older people. © 2010 Rila Publications Ltd.-
dc.languageeng-
dc.relation.ispartofCME Journal Geriatric Medicine-
dc.subjectAppropriate use-
dc.subjectDigoxin-
dc.subjectEfficacy-
dc.subjectTherapeutic range-
dc.subjectToxicity-
dc.titleSafe and effective use of digoxin in old age-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.scopuseid_2-s2.0-77955678335-
dc.identifier.volume12-
dc.identifier.issue2-
dc.identifier.spage86-
dc.identifier.epage97-
dc.identifier.issnl1475-1453-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats